dihexa safety toxicity Side Effects: The No-Human-Data Reality (2026) dihexa clinical trial human studies

Preclinical (animal) findings have likewise been mixed rather than conclusive

The strongest candidates are patients with documented poor sleep quality (especially inadequate slow-wave sleep), elevated or dysregulated cortisol, and co-existing metabolic markers such as insulin resistance, rising fasting glucose, low IGF-1, or visceral fat accumulation

et al.: PepT1mediated tripeptide KPV uptake reduces intestinal inflammation in DSS colitis models Innerbody Research (2025) KPV peptide benefits, safety, and administration routes

Beginners should always start at the lower end of their range and increase gradually if needed

Angew Chem